Reciprocal regulatory mechanism between miR-214-3p and FGFR1 in FGFR1-amplified lung cancer
出版年份 2019 全文链接
标题
Reciprocal regulatory mechanism between miR-214-3p and FGFR1 in FGFR1-amplified lung cancer
作者
关键词
-
出版物
Oncogenesis
Volume 8, Issue 9, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-09-06
DOI
10.1038/s41389-019-0151-1
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The Hippo/YAP1 pathway interacts with FGFR1 signaling to maintain stemness in lung cancer
- (2018) Tingting Lu et al. CANCER LETTERS
- Histologic Lung Cancer Incidence Rates and Trends Vary by Race/Ethnicity and Residential County
- (2018) Keisha A. Houston et al. Journal of Thoracic Oncology
- BGJ398 for FGFR -altered advanced cholangiocarcinoma
- (2018) Judith A Gilbert LANCET ONCOLOGY
- miR-19b enhances proliferation and apoptosis resistance via the EGFR signaling pathway by targeting PP2A and BIM in non-small cell lung cancer
- (2018) Ulrich Baumgartner et al. Molecular Cancer
- FGFR1-ERK1/2-SOX2 axis promotes cell proliferation, epithelial–mesenchymal transition, and metastasis in FGFR1-amplified lung cancer
- (2018) Kaixuan Wang et al. ONCOGENE
- MicroRNA-30a-5p inhibits gallbladder cancer cell proliferation, migration and metastasis by targeting E2F7
- (2018) Yuan-Yuan Ye et al. Cell Death & Disease
- Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1–3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with FGFR3 Alterations
- (2018) Sumanta K. Pal et al. Cancer Discovery
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- LY2874455 potently inhibits FGFR gatekeeper mutant and overcomes mutation-based resistance
- (2018) Daichao Wu et al. CHEMICAL COMMUNICATIONS
- A phase Ib study of BGJ398, a pan-FGFR kinase inhibitor in combination with imatinib in patients with advanced gastrointestinal stromal tumor
- (2018) Ciara M. Kelly et al. INVESTIGATIONAL NEW DRUGS
- MicroRNA-590-5p functions as a tumor suppressor in breast cancer conferring inhibitory effects on cell migration, invasion, and epithelial-mesenchymal transition by downregulating the Wnt-β-catenin signaling pathway
- (2018) Jin Gao et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The FGFR1 V561M Gatekeeper Mutation Drives AZD4547 Resistance through STAT3 Activation and EMT
- (2018) Molly R Ryan et al. MOLECULAR CANCER RESEARCH
- Therapeutic Silencing of miR-214 Inhibits Tumor Progression in Multiple Mouse Models
- (2018) Daniela Dettori et al. MOLECULAR THERAPY
- FEZF1-AS1 is a key regulator of cell cycle, epithelial–mesenchymal transition and Wnt/β-catenin signaling in nasopharyngeal carcinoma cells
- (2018) Yunzhou Cheng BIOSCIENCE REPORTS
- Long noncoding RNA HOTAIR knockdown inhibits autophagy and epithelial-mesenchymal transition through the Wnt signaling pathway in radioresistant human cervical cancer HeLa cells
- (2018) Xinggang Guo et al. JOURNAL OF CELLULAR PHYSIOLOGY
- MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway
- (2017) Qiuran Xu et al. Molecular Cancer
- EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
- (2017) Tsukasa Shibue et al. Nature Reviews Clinical Oncology
- A Phase 1 Study of LY2874455, an Oral Selective pan-FGFR Inhibitor, in Patients with Advanced Cancer
- (2017) Michael Michael et al. Targeted Oncology
- Down-regulation of miR-214 reverses erlotinib resistance in non-small-cell lung cancer through up-regulating LHX6 expression
- (2017) Jinrong Liao et al. Scientific Reports
- MiR-214 Attenuates Osteogenic Differentiation of Mesenchymal Stem Cells via Targeting FGFR1
- (2016) Lei Yang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- miR-296 inhibits proliferation and induces apoptosis by targeting FGFR1 in human hepatocellular carcinoma
- (2016) Liyan Wang et al. FEBS LETTERS
- miR-127 promotes EMT and stem-like traits in lung cancer through a feed-forward regulatory loop
- (2016) L Shi et al. ONCOGENE
- Wnt signaling in cancer
- (2016) T Zhan et al. ONCOGENE
- Amplification of FGFR1 gene and expression of FGFR1 protein is found in different histological types of lung carcinoma
- (2016) Vitor Sousa et al. VIRCHOWS ARCHIV
- Kinome RNAi Screens Reveal Synergistic Targeting of MTOR and FGFR1 Pathways for Treatment of Lung Cancer and HNSCC
- (2015) K. R. Singleton et al. CANCER RESEARCH
- The FGFR Landscape in Cancer: Analysis of 4,853 Tumors by Next-Generation Sequencing
- (2015) T. Helsten et al. CLINICAL CANCER RESEARCH
- Overexpression of miR-214-3p in esophageal squamous cancer cells enhances sensitivity to cisplatin by targeting survivin directly and indirectly through CUG-BP1
- (2015) P Phatak et al. ONCOGENE
- Co-active receptor tyrosine kinases mitigate the effect of FGFR inhibitors in FGFR1-amplified lung cancers with low FGFR1 protein expression
- (2015) H Kotani et al. ONCOGENE
- miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway
- (2015) Chenyang Zhao et al. RNA Biology
- Targeting the Wnt-Regulatory Protein CTNNBIP1 by microRNA-214 Enhances the Stemness and Self-Renewal of Cancer Stem-Like Cells in Lung Adenocarcinomas
- (2015) Wei Qi et al. STEM CELLS
- The Regulatory Role of MicroRNAs in EMT and Cancer
- (2015) Apostolos Zaravinos Journal of Oncology
- US lung cancer trends by histologic type
- (2014) Denise Riedel Lewis et al. CANCER
- Identification of MicroRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression
- (2014) Dong-liang Chen et al. HEPATOLOGY
- Comprehensive molecular profiling of lung adenocarcinoma
- (2014) Eric A. Collisson et al. NATURE
- MicroRNAs in cancer: biomarkers, functions and therapy
- (2014) Josie Hayes et al. TRENDS IN MOLECULAR MEDICINE
- The FGFR1 inhibitor PD173074 induces mesenchymal–epithelial transition through the transcription factor AP-1
- (2013) P T Nguyen et al. BRITISH JOURNAL OF CANCER
- STAT3 upregulates miR-92a to inhibit RECK expression and to promote invasiveness of lung cancer cells
- (2013) H-Y Lin et al. BRITISH JOURNAL OF CANCER
- Fibroblast growth factor receptor 1 (FGFR1) amplification is a potential therapeutic target in small-cell lung cancer
- (2013) Anne M Schultheis et al. MODERN PATHOLOGY
- AZD4547: An Orally Bioavailable, Potent, and Selective Inhibitor of the Fibroblast Growth Factor Receptor Tyrosine Kinase Family
- (2012) P. R. Gavine et al. CANCER RESEARCH
- Fibroblast Growth Factor Receptor 1 Gene Amplification Is Associated With Poor Survival and Cigarette Smoking Dosage in Patients With Resected Squamous Cell Lung Cancer
- (2012) Hye Ryun Kim et al. JOURNAL OF CLINICAL ONCOLOGY
- Down-regulation of miR-124/-214 in cutaneous squamous cell carcinoma mediates abnormal cell proliferation via the induction of ERK
- (2012) Keitaro Yamane et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- miR-20a Encoded by the miR-17-92 Cluster Increases the Metastatic Potential of Osteosarcoma Cells by Regulating Fas Expression
- (2011) G. Huang et al. CANCER RESEARCH
- Searching for the ‘melano-miRs’: miR-214 drives melanoma metastasis
- (2011) Menashe Bar-Eli EMBO JOURNAL
- microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C
- (2011) Elisa Penna et al. EMBO JOURNAL
- Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung Cancer
- (2011) Amit Dutt et al. PLoS One
- FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer
- (2010) N. Turner et al. CANCER RESEARCH
- Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer
- (2010) J. Weiss et al. Science Translational Medicine
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started